Predictions
Align Technology
Start price
Target price
Perf. (%)
€289.85
11.10.18
11.10.18
€455.96
04.11.21
04.11.21
103.07%
05.11.21
05.11.21
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.60
29.04.21
29.04.21
€245.00
29.04.22
29.04.22
-10.43%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€219.23
21.01.21
21.01.21
€215.00
2.46%
15.02.21
15.02.21
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€89.92
30.07.20
30.07.20
€125.00
04.11.21
04.11.21
44.97%
21.01.21
21.01.21
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€149.70
08.05.19
08.05.19
€159.35
20.06.19
20.06.19
6.45%
20.06.19
20.06.19
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€238.00
01.03.19
01.03.19
€243.54
21.03.19
21.03.19
2.43%
21.03.19
21.03.19
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€65.16
03.10.18
03.10.18
€65.85
03.12.18
03.12.18
1.83%
03.12.18
03.12.18
Could be worthwhile Investment >10% per year
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€60.75
07.09.18
07.09.18
€62.24
13.09.18
13.09.18
2.57%
13.09.18
13.09.18
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.84
09.03.18
09.03.18
€306.68
07.05.18
07.05.18
17.78%
07.05.18
07.05.18
Could be worthwhile Investment >10% per year
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€136.85
21.11.16
21.11.16
€150.00
21.02.17
21.02.17
10.28%
21.02.17
21.02.17
Johnson & Johnson
Start price
Target price
Perf. (%)
€86.15
28.11.14
28.11.14
€92.00
23.01.15
23.01.15
6.79%
23.01.15
23.01.15
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued